Skip to main content
Page Banner
July 24, 2019

LifeLabs partners with Maple to bring virtual care consultations for personalized testing to Canadian homes

Today, LifeLabs announced a new partnership with Maple, Canada’s leading virtual care platform which provides 24/7 on-demand instant access to doctors and other health care providers by secure text or video for advice, diagnosis, and medical care from wherever they are. By linking with Maple, Canadians can receive virtual consultations with a Naturopathic Doctor through Maple to access Rocky Mountain Analytical’s RMA FST™ IgG Food Sensitivity Test. In the future, Maple will also provide access to other LifeLabs offerings, such as pharmacogenetics service TreatGxPlus, making these important testing options even more convenient and accessible to Canadians across the country.

“Together with Maple, our collective goal is to increase access to diagnostic testing and empower today’s busy patient to receive the safest, highest quality care and treatment options, whenever and wherever they need it,” says Jennifer Flexman, Director, Product and Service Innovation at LifeLabs.

TreatGxPlus is a pharmacogenetic test which identifies genetic differences in a person’s DNA to identify how patients respond to different medications. By knowing a patient’s pharmacogenetic results, health care providers can tailor prescriptions to support personalized health care needs for patients by improving the effectiveness of medications, reducing adverse side effects, and providing safer, more effective treatment options.

The RMA FST™ provides a list of food sensitivities in an easy-to-interpret report, by analyzing hundreds of different types of food antigens through a simple blood test, taking the guesswork out of diets. Customers can consult with a Naturopathic Doctor, directly on Maple, to have the test ordered. If you are interested in exploring the FST test, simply go to getmaple.ca to create an account and request a consultation with a Naturopathic Doctor.

“Providing accessible health care available when and where Canadians need it has always been the top priority at Maple,” said Dr. Brett Belchetz, co-founder and CEO at Maple. “By bringing together our telemedicine platform and LifeLabs’ testing technologies, we’re now able to add a whole new lens to this goal by providing access to personalized health care, tailored to each person’s unique makeup.”

This partnership between LifeLabs and Maple will allow Canadians to personalize their own health journey.

More information is available in the official press release located here. [PDF]